Skip to main content

Beneficial ownership — 13D / 13G

85,706 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
FMR LLC RLAY Relay Therapeutics, Inc. 13G 9.4% 3mo
BERKLEY W R CORP PGAC PANTAGES CAPITAL ACQUISITION Corp 13G/A 8.3% 3mo
FMR LLC DPZ Dominos Pizza Inc 13G/A 12.4% 3mo
FMR LLC AFG American Financial Group Inc 13G/A 6.5% 3mo
FMR LLC SHOO Steven Madden, Ltd. 13G/A 9.7% 3mo
FJ Capital Management LLC HTB HomeTrust Bancshares, Inc. 13G/A 4.99% 3mo
PRIMECAP MANAGEMENT CO/CA/ MKTX Marketaxess Holdings Inc 13G/A 9.86% 3mo
FMR LLC ALLW SSGA Active Trust 13G/A 11.3% 3mo
FMR LLC CNR Core Natural Resources, Inc. 13G/A 5.7% 3mo
FMR LLC XPRO Expro Ltd 13G/A 5.9% 3mo
FMR LLC NXT Nextpower Inc. 13G/A 12.4% 3mo
FMR LLC NNN Nnn REIT, Inc. 13G/A 6% 3mo
FMR LLC OLLI Ollie's Bargain Outlet Holdings, Inc. 13G/A 14.5% 3mo
FMR LLC NG Novagold Resources Inc 13G/A 3.4% 3mo
First Eagle Investment Management, LLC SLP Simulations Plus, Inc. 13G 5.3% 3mo
FMR LLC AGRH iShares Interest Rate Hedged U.S. Aggregate Bond ETF 13G 6% 3mo
FMR LLC AAXJ iShares Trust 13G/A 12.6% 3mo
FMR LLC PAHC Phibro Animal Health Corp 13G/A 15% 3mo
First Eagle Investment Management, LLC BDX Becton Dickinson & Co 13G 5.1% 3mo
FMR LLC FIGR Figure Technology Solutions, Inc. 13G/A 5.3% 3mo
Capital World Investors ZG Zillow Group, Inc. 13G/A 4.9% 3mo
FMR LLC SCI Service Corp International 13G 5.9% 3mo
FMR LLC CVSA Covista Inc. 13G/A 9.5% 3mo
FMR LLC SSNC SS&C Technologies Holdings Inc 13G 5% 3mo
FMR LLC AVLN Avalyn Pharma Inc. 13G/A 13.2% 3mo
FMR LLC TRVI Trevi Therapeutics, Inc. 13G/A 8.8% 3mo
Grantham, Mayo, Van Otterloo & Co. LLC ARRY Array Technologies, Inc. 13G/A 7.73% 3mo
FMR LLC ZVRA Zevra Therapeutics, Inc. 13G/A 8.3% 3mo
FMR LLC ACLS Axcelis Technologies Inc 13G/A 13.4% 3mo
FMR LLC OVV Ovintiv Inc. 13G/A 9.2% 3mo
FMR LLC LEGN Legend Biotech Corp 13G/A 15% 3mo
FMR LLC HII Huntington Ingalls Industries, Inc. 13G/A 6.8% 3mo
FMR LLC SGI Somnigroup International Inc. 13G/A 12.5% 3mo
NATIXIS PSNY Polestar Automotive Holding UK PLC 13G 4.6% 3mo
FMR LLC PGNY Progyny, Inc. 13G/A 8.9% 3mo
FMR LLC AOS Smith A O Corp 13G/A 9.3% 3mo
PRIMECAP MANAGEMENT CO/CA/ BAH Booz Allen Hamilton Holding Corp 13G 5.34% 3mo
FMR LLC HCC Warrior Met Coal, Inc. 13G/A 4% 3mo
PRIMECAP MANAGEMENT CO/CA/ GRAL GRAIL, Inc. 13G/A 5.08% 3mo
FMR LLC MBC MasterBrand, Inc. 13G 5.1% 3mo
FMR LLC SYNA SYNAPTICS Inc 13G 5.7% 3mo
FMR LLC WAB Westinghouse Air Brake Technologies Corp 13G/A 12.7% 3mo
FMR LLC BIIB Biogen Inc. 13G/A 12.4% 3mo
MILLENNIUM MANAGEMENT LLC CTKB Cytek Biosciences, Inc. 13G/A 7.2% 3mo
FMR LLC MMS Maximus, Inc. 13G/A 10.6% 3mo
FMR LLC PRTA Prothena Corp Public Ltd Co 13G/A 13.8% 3mo
FMR LLC INO Inovio Pharmaceuticals, Inc. 13G/A 10.3% 3mo
FMR LLC DYN Dyne Therapeutics, Inc. 13G/A 6.8% 3mo
FMR LLC BCLO BlackRock ETF Trust II 13G 5.2% 3mo
FMR LLC JLL Jones Lang Lasalle Inc 13G/A 6.9% 3mo